Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target

Rong Bu; Prashant Bavi; Azhar R Hussain; Zeenath Jehan; Jehad Abubaker; Nasser A Al-Sanea; Alaa S Abduljabbar; Luai H Ashari; Samar J Al-Homoud; Fouad Al-Dayel

Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target

Rong Bu, Prashant Bavi, Azhar R Hussain, Zeenath Jehan, Jehad Abubaker, Nasser A Al-Sanea, Alaa S Abduljabbar, Luai H Ashari, Samar J Al-Homoud, Fouad Al-Dayel

Biochemistry and Molecular Biology

Research output: Other contribution

Original language	Undefined/Unknown
Publisher	American Association for Cancer Research Inc.
Publication status	Published - 2011

Cite this

Bu, R., Bavi, P., Hussain, A. R., Jehan, Z., Abubaker, J., Al-Sanea, N. A., Abduljabbar, A. S., Ashari, L. H., Al-Homoud, S. J., & Al-Dayel, F. (2011). Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target. American Association for Cancer Research Inc.

Bu, Rong ; Bavi, Prashant ; Hussain, Azhar R ; Jehan, Zeenath ; Abubaker, Jehad ; Al-Sanea, Nasser A ; Abduljabbar, Alaa S ; Ashari, Luai H ; Al-Homoud, Samar J ; Al-Dayel, Fouad. / Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target. 2011. American Association for Cancer Research Inc.

@misc{87da1c69d12a479dbb1b9406c07708b3,

title = "Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target",

author = "Rong Bu and Prashant Bavi and Hussain, {Azhar R} and Zeenath Jehan and Jehad Abubaker and Al-Sanea, {Nasser A} and Abduljabbar, {Alaa S} and Ashari, {Luai H} and Al-Homoud, {Samar J} and Fouad Al-Dayel",

year = "2011",

language = "Undefined/Unknown",

publisher = "American Association for Cancer Research Inc.",

address = "United States",

type = "Other",

}

Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target. / Bu, Rong; Bavi, Prashant; Hussain, Azhar R; Jehan, Zeenath; Abubaker, Jehad; Al-Sanea, Nasser A; Abduljabbar, Alaa S; Ashari, Luai H; Al-Homoud, Samar J; Al-Dayel, Fouad.

American Association for Cancer Research Inc.. 2011.

Research output: Other contribution

TY - GEN

T1 - Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target

AU - Bu, Rong

AU - Bavi, Prashant

AU - Hussain, Azhar R

AU - Jehan, Zeenath

AU - Abubaker, Jehad

AU - Al-Sanea, Nasser A

AU - Abduljabbar, Alaa S

AU - Ashari, Luai H

AU - Al-Homoud, Samar J

AU - Al-Dayel, Fouad

PY - 2011

Y1 - 2011

M3 - Other contribution

PB - American Association for Cancer Research Inc.

ER -